<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Blastocystis species</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Blastocystis species</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Blastocystis species</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Karin Leder, MBBS, FRACP, PhD, MPH, DTMH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Edward T Ryan, MD, DTMH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 23, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Blastocystis</em> species (previously referred to as <em>Blastocystis hominis</em>) are anaerobic protozoan parasites found in the human gastrointestinal tract [<a href="#rid1">1</a>]. The organism was initially discovered in 1911 and for many years was considered to be a harmless yeast. Studies in the 1970s demonstrated that <em>Blastocystis </em>spp are protozoans [<a href="#rid2">2,3</a>]. </p><p><em>Blastocystis </em>spp are the most common eukaryotic parasites found in human stool specimens, but there is considerable controversy regarding whether they represent a commensal organism or a true pathogen. Foci of particular study are how the presence of <em>Blastocystis </em>spp influences immune inflammatory responses in the gut microbiome and whether it is a potential marker of intestinal dysbiosis. </p><p>Issues related to nonpathogenic enteric protozoa are discussed further separately. (See  <a class="medical medical_review" href="/d/html/5730.html" rel="external">"Nonpathogenic enteric protozoa"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span><em>Blastocystis</em> spp have been observed worldwide. The organism resides in the colon and cecum of children and adults. The mode of and risk factors for transmission are not fully understood. The parasite is ubiquitous in the environment, and contaminated food, water, and soil are potential sources of infection through faecal-oral transmission [<a href="#rid4">4-7</a>]. The occurrence of <em>Blastocystis</em> spp in environmental water sources may be associated with climatic factors (eg, temperature) and water contamination (coliform count, turbidity, and total dissolved solids) [<a href="#rid8">8-10</a>]. <em>Blastocystis</em> spp have also been found in animals including pigs, monkeys, rodents, and poultry. There seems to be poor host specificity; transmission occurs from human to human and between humans and animals [<a href="#rid11">11-13</a>]. <em>Blastocystis</em> is more commonly found among individuals with occupational exposure to animals, supporting the potential for zoonotic transmission.</p><p>The prevalence of <em>Blastocystis</em> spp varies between countries and between communities, and according to the diagnostic techniques used [<a href="#rid1">1</a>]. In general, the estimated prevalence of <em>Blastocystis</em> spp is higher in resource-limited settings than resource-rich settings (30 to 50 percent versus 5 to 10 percent, respectively). Prevalence is highly variable, which may be related to poor hygiene, animal exposure, and consumption of contaminated food or water [<a href="#rid1">1</a>]. In one study from Senegal, 100 percent of 93 fecal samples were positive for <em>Blastocystis</em> spp [<a href="#rid14">14</a>]. In a study from Canada, 8 percent of stool samples submitted to a reference laboratory were positive for <em>Blastocystis</em> spp [<a href="#rid15">15</a>]. <em>Blastocystis</em> spp are also commonly found in the stool of returned travelers from resource-limited settings [<a href="#rid4">4,16</a>]. In one study of nearly 2000 stool specimens from travelers in Nepal, the prevalence of <em>Blastocystis</em> spp was 30 percent [<a href="#rid17">17</a>] (see  <a class="medical medical_review" href="/d/html/2709.html" rel="external">"Travelers' diarrhea: Epidemiology, microbiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3888.html" rel="external">"Evaluation of fever in the returning traveler"</a>). However, <em>Blastocystis</em> carriage in travelers is highly dynamic. In a study including more than 470 Dutch travelers who had stool samples taken before and after travel, 36 percent carried <em>Blastocystis</em> prior to travel; in 28 percent of these travelers, no <em>Blastocystis</em> or a different subtype was detected following travel [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H3"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>Blastocystis</em> spp demonstrate marked morphologic variability and measure between 5 and 40 mcm  (<a class="graphic graphic_picture graphicRef73525" href="/d/graphic/73525.html" rel="external">picture 1</a>). The organism lacks a cell wall but contains mitochondria, Golgi apparatus, and smooth and rough endoplasmic reticula typical of protozoa [<a href="#rid19">19</a>]. It reproduces asexually, usually by binary fission. It grows only under anaerobic conditions in culture, and it is highly susceptible to changes in temperature and in environmental tonicity.</p><p>Four different forms have been described: vacuolar, granular, ameboid, and cystic  (<a class="graphic graphic_figure graphicRef74028" href="/d/graphic/74028.html" rel="external">figure 1</a>) [<a href="#rid20">20,21</a>]. It is unknown whether transmission occurs more frequently during a particular stage or stages. The vacuolar form has a characteristic large central vacuole-like body that compresses the cytoplasm and nuclei to the periphery of the cell [<a href="#rid2">2</a>]. The vacuolar and cystic forms have been observed most frequently in stool samples. The ameboid stage is most frequently observed in old cultures or after antibiotic administration [<a href="#rid2">2</a>]. Some have suggested that the ameboid form of the organism is more likely to be associated with clinical disease [<a href="#rid22">22</a>]. The granular form is rarely seen in fresh stool.</p><p class="headingAnchor" id="H4"><span class="h2">Genetic variability</span><span class="headingEndMark"> — </span>Extreme genetic diversity has been described among <em>Blastocystis</em> isolates [<a href="#rid1">1,23</a>]. There are at least 28 different subtypes, at least 12 of which have been identified in humans. As a result, <em>Blastocystis</em> in humans is referred to as <em>Blastocystis</em> spp rather than <em>Blastocystis hominis</em> (the previously used term for <em>Blastocystis</em> in humans). This genetic and species diversity may account for the disparities of previous data in assessing the morphology, life cycle, and pathogenic role of <em>Blastocystis</em> spp.</p><p>Subtype 3 is the most frequently isolated genotype in epidemiologic surveys and is probably the only species of human origin [<a href="#rid24">24</a>]. Subtypes 1, 2, and 4 are the next most commonly isolated subtypes in humans [<a href="#rid25">25</a>]; other subtypes (ST5 to ST10, ST12, ST14 and ST16) represent under 10 percent of human infections [<a href="#rid25">25,26</a>]. Subtype 1 probably originates from mammals, subtype 2 is mainly from primates and pigs, subtype 4 is from rodents, subtype 5 seems to originate from cattle and pigs, and subtypes 6 and 7 are from birds [<a href="#rid1">1</a>]. A meta-analysis of <em>Blastocystis</em> spp prevalence in birds and rodents found estimates of 29 percent (95% CI 12-47) and 18 percent (95% CI 12-23), respectively [<a href="#rid27">27</a>]. Some subtypes have a particular geographic distribution, such as avian subtypes ST6 and ST7, which are more frequently found in Asia and the Middle East [<a href="#rid1">1</a>]. Infection with multiple subtypes has been described [<a href="#rid28">28</a>].</p><p>A review of <em>Blastocystis</em> spp subtypes and their distribution in humans in nine countries in North and South America showed that ST3 (37.9 percent), ST1 (33.3 percent), and ST2 (21.9 percent) were most common, with other subtypes each comprising &lt;2 percent of isolates [<a href="#rid29">29</a>]. In Asian countries, ST1 and ST3 are also the more prevalent subtypes, followed by ST2 [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H5"><span class="h1">PATHOGENICITY</span></p><p class="headingAnchor" id="H2850281598"><span class="h2">Uncertain pathogenic role</span><span class="headingEndMark"> — </span>There has been significant debate regarding whether <em>Blastocystis</em> spp are intestinal commensals, markers of dysbiosis, or true pathogens.</p><p>Some studies have suggested a pathogenic role for <em>Blastocystis</em> spp [<a href="#rid4">4,30-33</a>], while many other studies have shown no correlation between <em>Blastocystis</em> spp and symptoms [<a href="#rid15">15,19,34-36</a>]. Some studies have found that more symptoms were reported in those without <em>Blastocystis</em> spp identified [<a href="#rid37">37,38</a>], and there is increasing evidence that <em>Blastocystis</em> spp is likely to be a member of the normal human gastrointestinal microbiome [<a href="#rid39">39,40</a>].</p><p>A number of issues contribute to the controversy:</p><p class="bulletIndent1"><span class="glyph">●</span>Many of the reports that have suggested a pathogenic role for <em>Blastocystis</em> spp have been case reports and uncontrolled or retrospective series. However, properly controlled prospective studies about pathogenicity or the effect of specific therapy are lacking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Criteria are lacking for labeling a specimen as "positive" for <em>Blastocystis</em> spp; diagnostic methods differ, and increasing use of PCR on stool specimens is contributing to a rise in positive test results even among asymptomatic individuals.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The heterogeneity of <em>Blastocystis</em> spp strains, accompanied by variable virulence, might account for differences in pathogenicity. However, evidence remains inconclusive, with many studies showing no definite correlation between subtype or genotypes and pathogenicity [<a href="#rid41">41-48</a>]. Subtype 4 may be associated with better gut health due to beneficial impacts on the intestinal microbiome and immunity, whereas subtype 7 may be more likely to cause colonic tissue ulceration and diarrhea [<a href="#rid49">49</a>]. Emerging evidence suggests that subtype 1 and perhaps subtype 3 are most likely to be associated with symptoms, although subtype 3 isolates are not always associated with symptomatic infection [<a href="#rid1">1,49-51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged, irregular shedding of the organism can occur. One study showed that the shedding from day to day ranged from 0 to 17 parasites per 40x microscopic field [<a href="#rid52">52</a>]. One study described observation of <em>Blastocystis </em>spp two months after first observation in 75 percent of individuals in which it was the sole organism detected [<a href="#rid15">15</a>]. Many reports of <em>Blastocystis </em>spp could reflect prior infection with residual chronic carriage [<a href="#rid15">15,53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Data suggest <em>Blastocystis</em> spp are a stable component of intestinal microbiota and, by influencing the diversity of the gut microbiota composition, may be present more commonly in healthy individuals than in patients with infectious, functional, or inflammatory bowel disease [<a href="#rid40">40,54,55</a>]. Data unraveling the influence of <em>Blastocystis</em> spp subtype and tools differentiating asymptomatic colonization from infection are not yet available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intestinal microbiota may influence the pathogenicity and likelihood of symptomatic <em>Blastocystis</em> spp [<a href="#rid56">56</a>]. Infection with <em>Blastocystis</em> spp may also influence host immunological responses and levels of pro- and anti-inflammatory cytokines [<a href="#rid26">26,40,55,57-59</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Quantitation</span><span class="headingEndMark"> — </span>Some authors have suggested that <em>Blastocystis</em> spp are more likely to be pathogenic if &gt;5 organisms per oil immersion field are detected and that, in lower quantities, the organisms should be disregarded as a potential cause of symptoms [<a href="#rid60">60,61</a>]. However, others have found no association between parasite concentrations and symptoms [<a href="#rid4">4,15,17,34</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Copathogenicity</span><span class="headingEndMark"> — </span><em>Blastocystis</em> spp are often found in association with other potential pathogens; reports have suggested that the majority of patients with <em>Blastocystis</em> spp in their stools have an alternative etiology identified on further examination [<a href="#rid19">19</a>].</p><p>It is sometimes inferred that identification of <em>Blastocystis</em> spp in a stool specimen suggests another unidentified pathogen. As an example, one study examined up to six samples from 32 patients with stool specimens positive for <em>Blastocystis</em> spp; another pathogen was identified in 84 percent of cases [<a href="#rid34">34</a>]. Initiation of treatment for the other pathogen led to resolution of symptoms despite the persistence of <em>Blastocystis</em> spp in follow-up stool specimens. However, another study of patients with diarrhea in Nepal showed that <em>Blastocystis </em>spp did not serve this marker function for other enteric pathogens, which were detected in 68 and 71 percent of patients with and without <em>Blastocystis</em> spp, respectively [<a href="#rid17">17</a>].</p><p>An alternative explanation that has been suggested for the association between <em>Blastocystis</em> spp and other pathogens is that the parasite may be easier to identify in nonformed, watery stools [<a href="#rid17">17,19,62</a>]. It is also possible that an increase in symbiotic bacterial flora during diarrhea might enhance the growth of <em>Blastocystis</em> spp [<a href="#rid19">19</a>]. There is also increasing emerging evidence to support the hypothesis that <em>Blastocystis</em> might be linked to the changes in the gut microbiome, with gut bacteria potentially impacting on <em>Blastocystis</em> spp growth or pathogenicity and <em>Blastocystis</em> spp impacting on intestinal flora health or imbalances [<a href="#rid56">56,63-70</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Carrier state</span><span class="headingEndMark"> — </span>The large number of asymptomatic individuals with stools positive for <em>Blastocystis</em> spp suggests either nonpathogenicity or the existence of a carrier state. Other protozoa such as <em>Giardia</em> are often found in asymptomatic patients but are pathogens when associated with appropriate clinical symptoms. (See  <a class="medical medical_review" href="/d/html/5723.html" rel="external">"Giardiasis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>It is possible that individuals with immunity due to prior exposure may be more likely to have an asymptomatic infection [<a href="#rid71">71,72</a>]. Alternatively, pathologic effects might depend upon host factors such as lowered immunity or on disturbances of gastrointestinal function from other causes [<a href="#rid71">71</a>]. </p><p class="headingAnchor" id="H17218354"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Symptoms that have been associated with identification of <em>Blastocystis</em> spp in stool include watery diarrhea, nausea, anorexia, abdominal cramps, bloating, flatulence, urticaria, itch, and fatigue, although (as discussed above) whether there is a causal association is uncertain. Both acute diarrhea and chronic diarrhea have been reported. Fever is usually absent. Association with body mass index and nutritional status in children is variable [<a href="#rid73">73,74</a>].</p><p>Some studies have suggested a possible link between <em>Blastocystis </em>spp and irritable bowel syndrome (IBS) and inflammatory bowel disease, although findings have been inconsistent across studies. A causal relationship has not been proven and the association with different <em>Blastocystis</em> subtypes remains uncertain [<a href="#rid63">63,65,75-84</a>]. An association between <em>Blastocystis</em> spp and urticaria (acute and chronic) has also been described [<a href="#rid85">85-89</a>].</p><p>Symptoms have been described in both immunocompromised and immunocompetent hosts, including patients with HIV and transplant recipients [<a href="#rid32">32,90</a>]. While there are some reports of greater prevalence or pathogenicity in immunosuppressed patients, such as those with HIV and transplant recipients, these patients do not necessarily appear to have more severe symptoms [<a href="#rid91">91-94</a>].</p><p>Disseminated infection is rare; two case reports have described identification of the organism in synovial fluid and peritoneal fluid, respectively [<a href="#rid95">95,96</a>]. In another report, a child with appendicular peritonitis was found to have <em>Blastocystis </em>organisms in the stool, appendix, peritoneal fluid, and recto-uterine pouch [<a href="#rid97">97</a>].</p><p>Patients with <em>Blastocystis </em>do not have peripheral leukocytosis or eosinophilia. White cells in stool specimens are usually absent.</p><p>If endoscopy is performed, findings usually demonstrate a macroscopically normal-appearing mucosa, and histopathology generally does not demonstrate intestinal inflammation or mucosal invasion [<a href="#rid91">91,98,99</a>]. Not all studies exclude patients who have other pathogens found, so results can be difficult to interpret.</p><p class="headingAnchor" id="H11"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span><em>Blastocystis </em>spp are identified by examination of stool specimen(s) by light microscopy of stained smears or wet mounts. Microscopic identification can be complicated by the variety of forms of the organism that appear in stool specimens, difficulties in finding it in wet mounts, and disruption of the organism with stool concentration techniques  (<a class="graphic graphic_picture graphicRef73525" href="/d/graphic/73525.html" rel="external">picture 1</a> and <a class="graphic graphic_figure graphicRef74028" href="/d/graphic/74028.html" rel="external">figure 1</a>) [<a href="#rid31">31</a>]. Commonly used microscopic methods include a formol ethyl acetate concentration technique permanent stained smears (usually trichrome stained). Fecal leukocytes are generally absent.</p><p>A stool culture method is available but is not performed routinely even though it may be more sensitive than microscopy [<a href="#rid100">100,101</a>]. An enzyme-linked immunosorbent assay for detecting serum antibodies to <em>Blastocystis</em> spp has been developed but is also not routinely used [<a href="#rid102">102</a>].</p><p>Polymerase chain reaction (PCR) techniques with excellent sensitivity have also been developed, with increasing widespread availability [<a href="#rid103">103,104</a>]. However, since <em>Blastocystis </em>spp can often be found in asymptomatic individuals and since its pathogenicity is unclear, the clinical relevance finding a positive PCR result is debatable. Loop-mediated isothermal amplification (LAMP) techniques have also been developed [<a href="#rid105">105</a>]. Molecular tests to differentiate between strains are limited to research settings.</p><p class="headingAnchor" id="H15"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H2916266803"><span class="h2">Asymptomatic patients</span><span class="headingEndMark"> — </span>Asymptomatic patients with <em>Blastocystis</em> spp identified on stool examination do <strong>not</strong> warrant therapy given that it may be a commensal organism. This is discussed in detail elsewhere. (See <a class="local">'Uncertain pathogenic role'</a> above.) </p><p class="headingAnchor" id="H85046413"><span class="h2">Symptomatic patients</span></p><p class="headingAnchor" id="H2181072538"><span class="h3">Whether to treat</span><span class="headingEndMark"> — </span>Treatment in symptomatic patients is controversial. Our approach is to confirm that there is no other potential pathogen through review or repeat of a concentrated stool specimen and cultures for bacterial enteric pathogens. If another potential pathogen is identified, we direct therapy against that pathogen and evaluate for symptom resolution. Noninfectious causes of symptoms should also be excluded.</p><p>When no other pathogen or etiology is identified or if patients continue to have bothersome symptoms following treatment of another pathogen, we generally suggest a trial of treatment with agents that have reported efficacy against <em>Blastocystis</em> spp. However, given the ongoing debate regarding the pathogenicity of<em> Blastocystis </em>spp (see <a class="local">'Uncertain pathogenic role'</a> above), the aim of treatment is to try to improve symptoms or treat another unidentified pathogen rather than specifically to eradicate <em>Blastocystis </em>spp.</p><p>Therapy with various agents has been associated with a clinical response in observational studies and a few randomized trials, as discussed below. However, it is uncertain whether this response is related to eradication of <em>Blastocystis</em> spp or elimination of some other undetected pathogen. Additionally, therapeutic efficacy for <em>Blastocystis</em> spp is difficult to determine, as the infection is often self-limiting, with many mild cases resolving within approximately three days. </p><p class="headingAnchor" id="H835272011"><span class="h3">Preferred treatment agents</span><span class="headingEndMark"> — </span>As with the decision to treat symptomatic patients, the optimal approach to regimen selection is also uncertain. We generally suggest either <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> (500 to 750 mg orally three times daily for 5 to 10 days) or <a class="drug drug_general" data-topicid="10205" href="/d/drug information/10205.html" rel="external">tinidazole</a> (2 g orally once). If this fails to improve symptoms, <a class="drug drug_general" data-topicid="9742" href="/d/drug information/9742.html" rel="external">paromomycin</a> (500 mg three times daily for 7 to 10 days) can be tried, if available, either alone or in combination with a repeat metronidazole or tinidazole course. Our recommendation for monotherapy with metronidazole or tinidazole as a reasonable initial option is based on limited comparative data on monotherapy versus combination therapy, as well as uncertainty of whether <em>Blastocystis</em> spp is pathogenic and limited paromomycin availability. However, clinical context should be considered, and initial combination therapy is justifiable in the setting of acute and/or severe symptoms. Tinidazole is better tolerated than metronidazole, but its availability may also be limited. For those who cannot take metronidazole or tinidazole, we recommend paromomycin monotherapy. Other alternatives are discussed below. (See <a class="local">'Alternative treatment agents'</a> below.)</p><p>Efficacy data for <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> are mixed. As an example, in a randomized controlled trial of 50 patients with diarrhea in whom <em>Blastocystis</em> spp was the only stool pathogen identified, randomization to receipt of 10 days of metronidazole had no effect on stool consistency or abdominal symptoms compared with placebo [<a href="#rid106">106</a>]. In another RCT among 76 patients with diarrhea and <em>Blastocystis</em> as the only pathogen detected, metronidazole (1.5 g/day for 10 days) resulted in a higher rate of symptom resolution at one month (88 versus 14 percent) and six months (75 versus 33 percent) compared with placebo [<a href="#rid101">101</a>]. Some in vitro studies have shown good sensitivity of the organism to metronidazole [<a href="#rid107">107</a>], but other studies have reported resistance [<a href="#rid108">108-111</a>].</p><p>No efficacy data on <a class="drug drug_general" data-topicid="10205" href="/d/drug information/10205.html" rel="external">tinidazole</a> is available; efficacy is assumed based on evidence with <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a>, since it is a closely related drug.  </p><p>Observational studies and case series have reported clinical and parasitologic responses to <a class="drug drug_general" data-topicid="9742" href="/d/drug information/9742.html" rel="external">paromomycin</a> [<a href="#rid112">112-114</a>]<em>.</em> As an example, in one retrospective study, paromomycin was associated with the highest clinical response rate (77 percent) compared with <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> (38 percent) and no treatment (22 percent) [<a href="#rid114">114</a>]<em>.</em></p><p class="headingAnchor" id="H3254833328"><span class="h3">Alternative treatment agents</span><span class="headingEndMark"> — </span>Other agents which have been tried include <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (TMP-SMX) and <a class="drug drug_general" data-topicid="10105" href="/d/drug information/10105.html" rel="external">nitazoxanide</a>. Sometimes clinical improvement is reported as described below, but both parasitologic and clinical responses are variable, and whether treatment should be pursued remains controversial. Although we do not routinely use them, these agents are reasonable options in patients who have contraindications or intolerance to the preferred agents discussed above. (See <a class="local">'Preferred treatment agents'</a> above.)  </p><p class="bulletIndent1"><span class="glyph">●</span>TMP-SMX – In a case series of 53 symptomatic patients with two consecutive stool specimens positive for <em>Blastocystis </em>spp and negative for other pathogens, treatment with TMP-SMX (6 mg/kg TMP [maximum 320 mg] and 30 mg/kg SMX [maximum 1600 mg] per day for 7 days) was associated with symptom resolution in 74 percent, improvement without full resolution in another 19 percent, and microbiologic eradication in 94 percent of patients [<a href="#rid22">22</a>]. Additionally, in vitro studies have demonstrated good susceptibility to TMP-SMX in isolates resistant to other agents [<a href="#rid107">107,111</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10105" href="/d/drug information/10105.html" rel="external">Nitazoxanide</a> – In a randomized study of 84 individuals with diarrhea and <em>Blastocystis</em> spp in stool, treatment with nitazoxanide resulted in a higher rate of symptom resolution (86 versus 38 percent) compared with placebo [<a href="#rid115">115</a>]. Nitazoxanide dosing differed by age (patients 12 years or older: 500 mg tablet twice daily; patients 4 to 11 years: 200 mg in 10 mL suspension twice daily; patients 1 to 3 years: 100 mg in 5 mL suspension twice daily for 3 days). It is uncertain whether clinical responses were due to the effect on <em>Blastocystis</em> spp or on other unidentified pathogens, and other studies have not shown universal benefit [<a href="#rid112">112</a>]. </p><p></p><p>In vitro studies have shown good sensitivity of the organism to furazolidone, quinacrine, <a class="drug drug_general" data-topicid="9752" href="/d/drug information/9752.html" rel="external">pentamidine</a>, emetine [<a href="#rid107">107</a>], and <a class="drug drug_general" data-topicid="8641" href="/d/drug information/8641.html" rel="external">ivermectin</a> [<a href="#rid111">111</a>]. Diloxanide furoate is inactive. Clinical experience with using these agents for <em>Blastocystis</em> spp is limited.</p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong>–<strong> </strong><em>Blastocystis </em>spp have been observed worldwide; in general, the estimated prevalence of <em>Blastocystis</em> spp is higher in resource-limited than resource-rich settings. The mode of transmission is not fully understood; fecal-oral transmission has been postulated. <em>Blastocystis </em>spp have also been found in animals, and <em>Blastocystis</em> spp are more commonly observed in the stool of individuals with occupational exposure to animals. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology </strong>–<strong> </strong><em>Blastocystis</em> spp (previously referred to as <em>Blastocystis hominis</em>) are anaerobic protozoan parasites found in the human gastrointestinal tract. <em>Blastocystis</em> spp demonstrate marked morphologic variability. They measure between 5 and 40 mcm  (<a class="graphic graphic_picture graphicRef73525" href="/d/graphic/73525.html" rel="external">picture 1</a>), and four different forms have been described: vacuolar, granular, ameboid, and cystic  (<a class="graphic graphic_figure graphicRef74028" href="/d/graphic/74028.html" rel="external">figure 1</a>). Extensive genetic diversity has been described among <em>Blastocystis</em> isolates; nine different subtypes have been identified in humans. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis </strong>–<strong> </strong>There has been considerable controversy regarding whether <em>Blastocystis</em> spp represent a commensal organism, a marker of intestinal dysbiosis, or a true pathogen. <em>Blastocystis</em> spp are often found in association with other potential pathogens; reports have suggested that the majority of patients with <em>Blastocystis</em> spp in their stools have an alternative etiology identified on further examination. The number of organisms does not necessarily correlate with symptoms. (See <a class="local">'Copathogenicity'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong>–<strong> </strong>Symptoms that have been associated with identification of <em>Blastocystis</em> spp include diarrhea, nausea, anorexia, abdominal cramps, bloating, flatulence, urticaria, and fatigue. Watery diarrhea is usually described. Both acute diarrhea and chronic diarrhea have been reported. Fever is usually absent. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>–<strong> </strong>The diagnosis can be made by examination of stool specimen(s) by light microscopy of stained smears or wet mounts. Endoscopy usually shows a macroscopically normal-appearing mucosa, and histopathology generally does not demonstrate intestinal inflammation or mucosal invasion. Polymerase chain reaction (PCR) testing, including multiplex PCR on stool, is increasingly being used. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Asymptomatic patients </strong>–<strong> </strong>Asymptomatic patients found to have <em>Blastocystis </em>spp on stool examination do not warrant treatment. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic patients </strong>–<strong> </strong>Whether or not any treatment should be given for symptomatic patients with<em> Blastocystis</em> spp is controversial. For patients with bothersome symptoms, we ensure that other pathogens and noninfectious causes have been evaluated. If no other pathogen or etiology is identified, we suggest a trial of antimicrobial therapy fo<em>r Blastocystis </em>spp (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). We generally suggest <a class="drug drug_general" data-topicid="9646" href="/d/drug information/9646.html" rel="external">metronidazole</a> (500 to 750 mg three times daily for 5 to 10 days) or <a class="drug drug_general" data-topicid="10205" href="/d/drug information/10205.html" rel="external">tinidazole</a> (2 g once) as monotherapy. If symptoms are severe and/or persist after monotherapy with metronidazole or tinidazole, <a class="drug drug_general" data-topicid="9742" href="/d/drug information/9742.html" rel="external">paromomycin</a> (500 mg three times daily for 7 to 10 days) can be used as an alternative, either as monotherapy or in combination with metronidazole or tinidazole (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008; 21:639.</a></li><li><a class="nounderline abstract_t">Zierdt CH, Rude WS, Bull BS. Protozoan characteristics of Blastocystis hominis. Am J Clin Pathol 1967; 48:495.</a></li><li><a class="nounderline abstract_t">Zierdt CH. Studies of Blastocystis hominis. J Protozool 1973; 20:114.</a></li><li><a class="nounderline abstract_t">Kain KC, Noble MA, Freeman HJ, Barteluk RL. Epidemiology and clinical features associated with Blastocystis hominis infection. Diagn Microbiol Infect Dis 1987; 8:235.</a></li><li><a class="nounderline abstract_t">Leelayoova S, Rangsin R, Taamasri P, et al. Evidence of waterborne transmission of Blastocystis hominis. Am J Trop Med Hyg 2004; 70:658.</a></li><li><a class="nounderline abstract_t">Jinatham V, Wandee T, Nonebudsri C, et al. Blastocystis subtypes in raw vegetables from street markets in northern Thailand. Parasitol Res 2023; 122:1027.</a></li><li><a class="nounderline abstract_t">Martín-Escolano R, Ng GC, Tan KSW, et al. Resistance of Blastocystis to chlorine and hydrogen peroxide. Parasitol Res 2023; 122:167.</a></li><li><a class="nounderline abstract_t">Attah AO, Sanggari A, Li LI, et al. Blastocystis occurrence in water sources worldwide from 2005 to 2022: a review. Parasitol Res 2023; 122:1.</a></li><li><a class="nounderline abstract_t">Ake-Canche B, Rodriguez-Bataz E, Esquivel-Piña JY, et al. Can the genetic variability of Blastocystis sp. be associated with the climatic region of its human carriers? Infect Genet Evol 2022; 106:105383.</a></li><li><a class="nounderline abstract_t">Nemati S, Zali MR, Johnson P, et al. Molecular prevalence and subtype distribution of Blastocystis sp. in Asia and in Australia. J Water Health 2021; 19:687.</a></li><li><a class="nounderline abstract_t">Parkar U, Traub RJ, Kumar S, et al. Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential. Parasitology 2007; 134:359.</a></li><li><a class="nounderline abstract_t">Hernández PC, Maloney JG, Molokin A, et al. Exploring Blastocystis genetic diversity in rural schoolchildren from Colombia using next-generation amplicon sequencing reveals significant associations between contact with animals and infection risk. Parasitol Res 2023; 122:1451.</a></li><li><a class="nounderline abstract_t">Chen H, Hao Y, Liu Y, et al. The frequency and subtype distribution of Blastocystis sp. in humans and domestic animals in households in Heilongjiang Province, China. Acta Trop 2023; 240:106844.</a></li><li><a class="nounderline abstract_t">El Safadi D, Gaayeb L, Meloni D, et al. Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 2014; 14:164.</a></li><li><a class="nounderline abstract_t">Senay H, MacPherson D. Blastocystis hominis: epidemiology and natural history. J Infect Dis 1990; 162:987.</a></li><li><a class="nounderline abstract_t">Jelinek T, Peyerl G, Löscher T, et al. The role of Blastocystis hominis as a possible intestinal pathogen in travellers. J Infect 1997; 35:63.</a></li><li><a class="nounderline abstract_t">Shlim DR, Hoge CW, Rajah R, et al. Is Blastocystis hominis a cause of diarrhea in travelers? A prospective controlled study in Nepal. Clin Infect Dis 1995; 21:97.</a></li><li><a class="nounderline abstract_t">van Hattem JM, Arcilla MS, Schultsz C, et al. Carriage of Blastocystis spp. in travellers - A prospective longitudinal study. Travel Med Infect Dis 2019; 27:87.</a></li><li><a class="nounderline abstract_t">Miller RA, Minshew BH. Blastocystis hominis: an organism in search of a disease. Rev Infect Dis 1988; 10:930.</a></li><li><a class="nounderline abstract_t">Zaman V, Howe J, Ng M. Variation in the cyst morphology of Blastocystis hominis. Parasitol Res 1997; 83:306.</a></li><li><a class="nounderline abstract_t">Moe KT, Singh M, Howe J, et al. Observations on the ultrastructure and viability of the cystic stage of Blastocystis hominis from human feces. Parasitol Res 1996; 82:439.</a></li><li><a class="nounderline abstract_t">Ok UZ, Girginkardeşler N, Balcioğlu C, et al. Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol 1999; 94:3245.</a></li><li><a class="nounderline abstract_t">Gentekaki E, Curtis BA, Stairs CW, et al. Extreme genome diversity in the hyper-prevalent parasitic eukaryote Blastocystis. PLoS Biol 2017; 15:e2003769.</a></li><li><a class="nounderline abstract_t">Wong KH, Ng GC, Lin RT, et al. Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res 2008; 102:663.</a></li><li><a class="nounderline abstract_t">Popruk S, Adao DEV, Rivera WL. Epidemiology and subtype distribution of Blastocystis in humans: A review. Infect Genet Evol 2021; 95:105085.</a></li><li><a class="nounderline abstract_t">Sardinha-Silva A, Alves-Ferreira EVC, Grigg ME. Intestinal immune responses to commensal and pathogenic protozoa. Front Immunol 2022; 13:963723.</a></li><li><a class="nounderline abstract_t">Barati M, KarimiPourSaryazdi A, Rahmanian V, et al. Global prevalence and subtype distribution of Blastocystis sp. in rodents, birds, and water supplies: A systematic review and meta-analysis. Prev Vet Med 2022; 208:105770.</a></li><li><a class="nounderline abstract_t">Scanlan PD, Stensvold CR, Cotter PD. Development and Application of a Blastocystis Subtype-Specific PCR Assay Reveals that Mixed-Subtype Infections Are Common in a Healthy Human Population. Appl Environ Microbiol 2015; 81:4071.</a></li><li><a class="nounderline abstract_t">Jiménez PA, Jaimes JE, Ramírez JD. A summary of Blastocystis subtypes in North and South America. Parasit Vectors 2019; 12:376.</a></li><li><a class="nounderline abstract_t">Zierdt CH. Pathogenicity of Blastocystis hominis. J Clin Microbiol 1991; 29:662.</a></li><li><a class="nounderline abstract_t">Zierdt CH. Blastocystis hominis--past and future. Clin Microbiol Rev 1991; 4:61.</a></li><li><a class="nounderline abstract_t">Blastocystis hominis as a human pathogen. Rev Infect Dis 1989; 11:661.</a></li><li><a class="nounderline abstract_t">Qadri SM, al-Okaili GA, al-Dayel F. Clinical significance of Blastocystis hominis. J Clin Microbiol 1989; 27:2407.</a></li><li><a class="nounderline abstract_t">Markell EK, Udkow MP. Blastocystis hominis: pathogen or fellow traveler? Am J Trop Med Hyg 1986; 35:1023.</a></li><li><a class="nounderline abstract_t">Sun T, Katz S, Tanenbaum B, Schenone C. Questionable clinical significance of Blastocystis hominis infection. Am J Gastroenterol 1989; 84:1543.</a></li><li><a class="nounderline abstract_t">Chen TL, Chan CC, Chen HP, et al. Clinical characteristics and endoscopic findings associated with Blastocystis hominis in healthy adults. Am J Trop Med Hyg 2003; 69:213.</a></li><li><a class="nounderline abstract_t">de Boer MD, Schuurs TA, Vermeer M, et al. Distribution and relevance of Dientamoeba fragilis and Blastocystis species in gastroenteritis: results from a case-control study. Eur J Clin Microbiol Infect Dis 2020; 39:197.</a></li><li><a class="nounderline abstract_t">Asghari A, Hassanipour S, Hatam G. Comparative molecular prevalence and subtypes distribution of Blastocystis sp. a potentially zoonotic infection isolated from symptomatic and asymptomatic patients in Iran: A systematic review and meta-analysis. Acta Parasitol 2021; 66:745.</a></li><li><a class="nounderline abstract_t">Scanlan PD, Stensvold CR, Rajilić-Stojanović M, et al. The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol 2014; 90:326.</a></li><li><a class="nounderline abstract_t">Deng L, Wojciech L, Gascoigne NRJ, et al. New insights into the interactions between Blastocystis, the gut microbiota, and host immunity. PLoS Pathog 2021; 17:e1009253.</a></li><li><a class="nounderline abstract_t">Clark CG. Extensive genetic diversity in Blastocystis hominis. Mol Biochem Parasitol 1997; 87:79.</a></li><li><a class="nounderline abstract_t">Yoshikawa H, Nagano I, Wu Z, et al. Genomic polymorphism among Blastocystis hominis strains and development of subtype-specific diagnostic primers. Mol Cell Probes 1998; 12:153.</a></li><li><a class="nounderline abstract_t">Kukoschke KG, Müller HE. SDS-PAGE and immunological analysis of different axenic Blastocystis hominis strains. J Med Microbiol 1991; 35:35.</a></li><li><a class="nounderline abstract_t">Boreham PF, Upcroft JA, Dunn LA. Protein and DNA evidence for two demes of Blastocystis hominis from humans. Int J Parasitol 1992; 22:49.</a></li><li><a class="nounderline abstract_t">Elwakil HS, Talaat RM. Genetic analysis of Blastocystis hominis isolated from symptomatic and asymptomatic human hosts in Egypt. J Egypt Soc Parasitol 2009; 39:99.</a></li><li><a class="nounderline abstract_t">Souppart L, Sanciu G, Cian A, et al. Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res 2009; 105:413.</a></li><li><a class="nounderline abstract_t">El Safadi D, Cian A, Nourrisson C, et al. Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France. BMC Infect Dis 2016; 16:451.</a></li><li><a class="nounderline abstract_t">Alinaghizade A, Mirjalali H, Mohebali M, et al. Inter- and intra-subtype variation of Blastocystis subtypes isolated from diarrheic and non-diarrheic patients in Iran. Infect Genet Evol 2017; 50:77.</a></li><li><a class="nounderline abstract_t">Feranmi F. Blastocystis subtype 4 linked to gut microbiota stability. Lancet Microbe 2022; 3:e564.</a></li><li><a class="nounderline abstract_t">Tan TC, Suresh KG, Smith HV. Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential. Parasitol Res 2008; 104:85.</a></li><li><a class="nounderline abstract_t">Mohamed RT, El-Bali MA, Mohamed AA, et al. Subtyping of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Makkah, Saudi Arabia. Parasit Vectors 2017; 10:174.</a></li><li><a class="nounderline abstract_t">Vennila GD, Suresh Kumar G, Khairul Anuar A, et al. Irregular shedding of Blastocystis hominis. Parasitol Res 1999; 85:162.</a></li><li><a class="nounderline abstract_t">Keystone JS. Blastocystis hominis and traveler's diarrhea. Clin Infect Dis 1995; 21:102.</a></li><li><a class="nounderline abstract_t">Andersen LO, Stensvold CR. Blastocystis in Health and Disease: Are We Moving from a Clinical to a Public Health Perspective? J Clin Microbiol 2016; 54:524.</a></li><li><a class="nounderline abstract_t">Beyhan YE, Yıldız MR. Microbiota and parasite relationship. Diagn Microbiol Infect Dis 2023; 106:115954.</a></li><li><a class="nounderline abstract_t">Rajamanikam A, Isa MNM, Samudi C, et al. Gut bacteria influence Blastocystis sp. phenotypes and may trigger pathogenicity. PLoS Negl Trop Dis 2023; 17:e0011170.</a></li><li><a class="nounderline abstract_t">Deng L, Wojciech L, Png CW, et al. Colonization with ubiquitous protist Blastocystis ST1 ameliorates DSS-induced colitis and promotes beneficial microbiota and immune outcomes. NPJ Biofilms Microbiomes 2023; 9:22.</a></li><li><a class="nounderline abstract_t">Rojas-Velázquez L, Morán P, Serrano-Vázquez A, et al. The regulatory function of Blastocystis spp. on the immune inflammatory response in the gut microbiome. Front Cell Infect Microbiol 2022; 12:967724.</a></li><li><a class="nounderline abstract_t">Ismail MH, Molan AL, Abbas SK. Serological levels of cytokines in irritable bowel syndrome (IBS) patients and non-IBS subjects with and without Blastocystis spp. infection. Ann Parasitol 2022; 68:77.</a></li><li><a class="nounderline abstract_t">Nimri LF. Evidence of an epidemic of Blastocystis hominis infections in preschool children in northern Jordan. J Clin Microbiol 1993; 31:2706.</a></li><li><a class="nounderline abstract_t">Sheehan DJ, Raucher BG, McKitrick JC. Association of Blastocystis hominis with signs and symptoms of human disease. J Clin Microbiol 1986; 24:548.</a></li><li><a class="nounderline abstract_t">Markell EK. Is there any reason to continue treating Blastocystis infections? Clin Infect Dis 1995; 21:104.</a></li><li><a class="nounderline abstract_t">Nourrisson C, Scanzi J, Pereira B, et al. Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One 2014; 9:e111868.</a></li><li><a class="nounderline abstract_t">Stensvold CR, Clark CG. Current status of Blastocystis: A personal view. Parasitol Int 2016; 65:763.</a></li><li><a class="nounderline abstract_t">Nagel R, Traub RJ, Allcock RJ, et al. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome 2016; 4:47.</a></li><li><a class="nounderline abstract_t">Kaur CP, Yong CC, Rajamanikam A, et al. The role and influence of bacteria on the growth of Blastocystis sp. subtype 3. Parasitol Res 2023; 122:1463.</a></li><li><a class="nounderline abstract_t">Deng L, Lee JWJ, Tan KSW. Infection with pathogenic Blastocystis ST7 is associated with decreased bacterial diversity and altered gut microbiome profiles in diarrheal patients. Parasit Vectors 2022; 15:312.</a></li><li><a class="nounderline abstract_t">Behboud S, Solhjoo K, Erfanian S, et al. Alteration of gut bacteria composition among individuals with asymptomatic Blastocystis infection: A case-control study. Microb Pathog 2022; 169:105639.</a></li><li><a class="nounderline abstract_t">Jeffery IB, Cotter PD, Scanlan PD. Collateral Damage in the Human Gut Microbiome - Blastocystis Is Significantly Less Prevalent in an Antibiotic-Treated Adult Population Compared to Non-Antibiotic Treated Controls. Front Cell Infect Microbiol 2022; 12:822475.</a></li><li><a class="nounderline abstract_t">Cinek O, Polackova K, Odeh R, et al. Blastocystis in the faeces of children from six distant countries: prevalence, quantity, subtypes and the relation to the gut bacteriome. Parasit Vectors 2021; 14:399.</a></li><li><a class="nounderline abstract_t">Blastocystis hominis: commensal or pathogen? Lancet 1991; 337:521.</a></li><li><a class="nounderline abstract_t">Cirioni O, Giacometti A, Drenaggi D, et al. Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts. Eur J Epidemiol 1999; 15:389.</a></li><li><a class="nounderline abstract_t">McCain A, Gruneck L, Popluechai S, et al. Circulation and colonisation of Blastocystis subtypes in schoolchildren of various ethnicities in rural northern Thailand. Epidemiol Infect 2023; 151:e77.</a></li><li><a class="nounderline abstract_t">Zaman Wahid B, Haque MA, Gazi MA, et al. Site-Specific Incidence Rate of Blastocystis hominis and Its Association with Childhood Malnutrition: Findings from a Multi-Country Birth Cohort Study. Am J Trop Med Hyg 2023; 108:887.</a></li><li><a class="nounderline abstract_t">Giacometti A, Cirioni O, Fiorentini A, et al. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999; 18:436.</a></li><li><a class="nounderline abstract_t">Yakoob J, Jafri W, Jafri N, et al. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 2004; 70:383.</a></li><li><a class="nounderline abstract_t">Tungtrongchitr A, Manatsathit S, Kositchaiwat C, et al. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 2004; 35:705.</a></li><li><a class="nounderline abstract_t">Stensvold CR, Lewis HC, Hammerum AM, et al. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect 2009; 137:1655.</a></li><li><a class="nounderline abstract_t">Yakoob J, Jafri W, Beg MA, et al. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010; 107:679.</a></li><li><a class="nounderline abstract_t">Khademvatan S, Masjedizadeh R, Rahim F, et al. Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients. Parasitol Int 2017; 66:142.</a></li><li><a class="nounderline abstract_t">Das R, Khalil S, Mirdha BR, et al. Molecular Characterization and Subtyping of Blastocystis Species in Irritable Bowel Syndrome Patients from North India. PLoS One 2016; 11:e0147055.</a></li><li><a class="nounderline abstract_t">Ismail MH, Abbas SK, Molan AL. Prevalence and subtype diversity of Blastocystis sp. in an Iraqi population with and without irritable bowel syndrome (IBS). Ann Parasitol 2022; 68:275.</a></li><li><a class="nounderline abstract_t">Unalan-Altintop T, Vahabov C, Ergunay K, et al. Investigation of Dientamoeba fragilis and Blastocystis in patients from Turkey with ulcerative colitis and irritable bowel syndrome: Any relation with genotypes? Acta Trop 2022; 231:106451.</a></li><li><a class="nounderline abstract_t">Abedi SH, Fazlzadeh A, Mollalo A, et al. The neglected role of Blastocystis sp. and Giardia lamblia in development of irritable bowel syndrome: A systematic review and meta-analysis. Microb Pathog 2022; 162:105215.</a></li><li><a class="nounderline abstract_t">Hameed DM, Hassanin OM, Zuel-Fakkar NM. Association of Blastocystis hominis genetic subtypes with urticaria. Parasitol Res 2011; 108:553.</a></li><li><a class="nounderline abstract_t">Casero RD, Mongi F, Sánchez A, Ramírez JD. Blastocystis and urticaria: Examination of subtypes and morphotypes in an unusual clinical manifestation. Acta Trop 2015; 148:156.</a></li><li><a class="nounderline abstract_t">Örsten S, Baysal İ, Akdoğan N, et al. Possible microRNA-based mechanism underlying relationship between chronic spontaneous urticaria and Blastocystis. Exp Parasitol 2023; 245:108453.</a></li><li><a class="nounderline abstract_t">Tuzer C, Yegit O, Ozturk NS, et al. Relationship between Blastocystis spp. with Accompanying Food Hypersensitivity and Chronic Spontaneous Urticaria. Int Arch Allergy Immunol 2022; 183:1259.</a></li><li><a class="nounderline abstract_t">Aykur M, Camyar A, Türk BG, et al. Evaluation of association with subtypes and alleles of Blastocystis with chronic spontaneous urticaria. Acta Trop 2022; 231:106455.</a></li><li><a class="nounderline abstract_t">Albrecht H, Stellbrink HJ, Koperski K, Greten H. Blastocystis hominis in human immunodeficiency virus-related diarrhea. Scand J Gastroenterol 1995; 30:909.</a></li><li><a class="nounderline abstract_t">Zuckerman MJ, Watts MT, Ho H, Meriano FV. Blastocystis hominis infection and intestinal injury. Am J Med Sci 1994; 308:96.</a></li><li><a class="nounderline abstract_t">Llibre JM, Tor J, Manterola JM, et al. Blastocystis hominis chronic diarrhoea in AIDS patients. Lancet 1989; 1:221.</a></li><li><a class="nounderline abstract_t">Asghari A, Sadeghipour Z, Hassanipour S, et al. Association between Blastocystis sp. infection and immunocompromised patients: a systematic review and meta-analysis. Environ Sci Pollut Res Int 2021; 28:60308.</a></li><li><a class="nounderline abstract_t">Khorshidvand Z, Khazaei S, Amiri M, et al. Worldwide prevalence of emerging parasite Blastocystis in immunocompromised patients: A systematic review and meta-analysis. Microb Pathog 2021; 152:104615.</a></li><li><a class="nounderline abstract_t">Lee MG, Rawlins SC, Didier M, DeCeulaer K. Infective arthritis due to Blastocystis hominis. Ann Rheum Dis 1990; 49:192.</a></li><li><a class="nounderline abstract_t">Patino WD, Cavuoti D, Banerjee SK, et al. Cytologic diagnosis of blastocystis hominis in peritoneal fluid: a case report. Acta Cytol 2008; 52:718.</a></li><li><a class="nounderline abstract_t">Fréalle E, El Safadi D, Cian A, et al. Acute blastocystis-associated appendicular peritonitis in a child, Casablanca, Morocco. Emerg Infect Dis 2015; 21:91.</a></li><li><a class="nounderline abstract_t">Horiki N, Maruyama M, Fujita Y, et al. Epidemiologic survey of Blastocystis hominis infection in Japan. Am J Trop Med Hyg 1997; 56:370.</a></li><li><a class="nounderline abstract_t">Zuckerman MJ, Ho H, Hooper L, et al. Frequency of recovery of Blastocystis hominis in clinical practice. J Clin Gastroenterol 1990; 12:525.</a></li><li><a class="nounderline abstract_t">Suresh K, Smith H. Comparison of methods for detecting Blastocystis hominis. Eur J Clin Microbiol Infect Dis 2004; 23:509.</a></li><li><a class="nounderline abstract_t">Nigro L, Larocca L, Massarelli L, et al. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 2003; 10:128.</a></li><li><a class="nounderline abstract_t">Zierdt CH, Zierdt WS, Nagy B. Enzyme-linked immunosorbent assay for detection of serum antibody to Blastocystis hominis in symptomatic infections. J Parasitol 1995; 81:127.</a></li><li><a class="nounderline abstract_t">Jones MS 2nd, Ganac RD, Hiser G, et al. Detection of Blastocystis from stool samples using real-time PCR. Parasitol Res 2008; 103:551.</a></li><li><a class="nounderline abstract_t">Roberts T, Barratt J, Harkness J, et al. Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of blastocystis sp. in clinical stool samples. Am J Trop Med Hyg 2011; 84:308.</a></li><li><a class="nounderline abstract_t">Badparva E, Javadi Mamaghani A, Kheirandish F, et al. Development and evaluation of a loop-mediated isothermal amplification (LAMP) technique for rapid, accurate, and specific detection of Blastocystis spp. in AIDS patients. Infection 2022; 50:1295.</a></li><li><a class="nounderline abstract_t">Cobuccio LG, Laurent M, Gardiol C, et al. Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial. J Travel Med 2023; 30.</a></li><li><a class="nounderline abstract_t">Wolfe MS. The treatment of intestinal protozoan infections. Med Clin North Am 1982; 66:707.</a></li><li><a class="nounderline abstract_t">Zaman V, Zaki M. Resistance of Blastocystis hominis cysts to metronidazole. Trop Med Int Health 1996; 1:677.</a></li><li><a class="nounderline abstract_t">Haresh K, Suresh K, Khairul Anus A, Saminathan S. Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 1999; 4:274.</a></li><li><a class="nounderline abstract_t">Rajamanikam A, Hooi HS, Kudva M, et al. Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence. PLoS One 2019; 14:e0212542.</a></li><li><a class="nounderline abstract_t">Roberts T, Bush S, Ellis J, et al. In Vitro Antimicrobial Susceptibility Patterns of Blastocystis. Antimicrob Agents Chemother 2015; 59:4417.</a></li><li><a class="nounderline abstract_t">Roberts T, Ellis J, Harkness J, et al. Treatment failure in patients with chronic Blastocystis infection. J Med Microbiol 2014; 63:252.</a></li><li><a class="nounderline abstract_t">Armentia A, Méndez J, Gómez A, et al. Urticaria by Blastocystis hominis. Successful treatment with paromomycin. Allergol Immunopathol (Madr) 1993; 21:149.</a></li><li><a class="nounderline abstract_t">van Hellemond JJ, Molhoek N, Koelewijn R, et al. Is paromomycin the drug of choice for eradication of Blastocystis in adults? J Infect Chemother 2013; 19:545.</a></li><li><a class="nounderline abstract_t">Rossignol JF, Kabil SM, Said M, et al. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 2005; 3:987.</a></li></ol></div><div id="topicVersionRevision">Topic 5672 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18854485" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : New insights on classification, identification, and clinical relevance of Blastocystis spp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6058384" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Protozoan characteristics of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4690644" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Studies of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3449317" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Epidemiology and clinical features associated with Blastocystis hominis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15211009" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Evidence of waterborne transmission of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36658225" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Blastocystis subtypes in raw vegetables from street markets in northern Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36378332" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Resistance of Blastocystis to chlorine and hydrogen peroxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36434314" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Blastocystis occurrence in water sources worldwide from 2005 to 2022: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36336275" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Can the genetic variability of Blastocystis sp. be associated with the climatic region of its human carriers?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34665764" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Molecular prevalence and subtype distribution of Blastocystis sp. in Asia and in Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17052374" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Direct characterization of Blastocystis from faeces by PCR and evidence of zoonotic potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37156906" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Exploring Blastocystis genetic diversity in rural schoolchildren from Colombia using next-generation amplicon sequencing reveals significant associations between contact with animals and infection risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36706827" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The frequency and subtype distribution of Blastocystis sp. in humans and domestic animals in households in Heilongjiang Province, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24666632" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2401797" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Blastocystis hominis: epidemiology and natural history.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9279726" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The role of Blastocystis hominis as a possible intestinal pathogen in travellers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7578767" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Is Blastocystis hominis a cause of diarrhea in travelers? A prospective controlled study in Nepal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29929001" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Carriage of Blastocystis spp. in travellers - A prospective longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3055191" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Blastocystis hominis: an organism in search of a disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9089732" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Variation in the cyst morphology of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8738284" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Observations on the ultrastructure and viability of the cystic stage of Blastocystis hominis from human feces.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10566723" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28892507" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Extreme genome diversity in the hyper-prevalent parasitic eukaryote Blastocystis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18064490" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34530156" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Epidemiology and subtype distribution of Blastocystis in humans: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36211380" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Intestinal immune responses to commensal and pathogenic protozoa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36181747" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Global prevalence and subtype distribution of Blastocystis sp. in rodents, birds, and water supplies: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25841010" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Development and Application of a Blastocystis Subtype-Specific PCR Assay Reveals that Mixed-Subtype Infections Are Common in a Healthy Human Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31358042" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A summary of Blastocystis subtypes in North and South America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2037690" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pathogenicity of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2004348" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Blastocystis hominis--past and future.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2772470" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Blastocystis hominis as a human pathogen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2808664" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical significance of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3766850" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Blastocystis hominis: pathogen or fellow traveler?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2596457" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Questionable clinical significance of Blastocystis hominis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13677378" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Clinical characteristics and endoscopic findings associated with Blastocystis hominis in healthy adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31659566" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Distribution and relevance of Dientamoeba fragilis and Blastocystis species in gastroenteritis: results from a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33686524" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Comparative molecular prevalence and subtypes distribution of Blastocystis sp. a potentially zoonotic infection isolated from symptomatic and asymptomatic patients in Iran: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25077936" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33630979" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : New insights into the interactions between Blastocystis, the gut microbiota, and host immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9233675" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Extensive genetic diversity in Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9664577" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Genomic polymorphism among Blastocystis hominis strains and development of subtype-specific diagnostic primers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1906543" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : SDS-PAGE and immunological analysis of different axenic Blastocystis hominis strains.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1563920" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Protein and DNA evidence for two demes of Blastocystis hominis from humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19530613" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Genetic analysis of Blastocystis hominis isolated from symptomatic and asymptomatic human hosts in Egypt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19290540" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Molecular epidemiology of human Blastocystis isolates in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27566417" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28238960" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Inter- and intra-subtype variation of Blastocystis subtypes isolated from diarrheic and non-diarrheic patients in Iran.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35907427" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Blastocystis subtype 4 linked to gut microbiota stability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18795333" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28388938" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Subtyping of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Makkah, Saudi Arabia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9934969" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Irregular shedding of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7578716" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Blastocystis hominis and traveler's diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26677249" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Blastocystis in Health and Disease: Are We Moving from a Clinical to a Public Health Perspective?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37267741" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Microbiota and parasite relationship.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36989208" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Gut bacteria influence Blastocystis sp. phenotypes and may trigger pathogenicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37185924" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Colonization with ubiquitous protist Blastocystis ST1 ameliorates DSS-induced colitis and promotes beneficial microbiota and immune outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36118018" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The regulatory function of Blastocystis spp. on the immune inflammatory response in the gut microbiome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35491688" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Serological levels of cytokines in irritable bowel syndrome (IBS) patients and non-IBS subjects with and without Blastocystis spp. infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8253970" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Evidence of an epidemic of Blastocystis hominis infections in preschool children in northern Jordan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3771743" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Association of Blastocystis hominis with signs and symptoms of human disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7578717" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Is there any reason to continue treating Blastocystis infections?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25365580" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27247124" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Current status of Blastocystis: A personal view.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27580855" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37162590" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The role and influence of bacteria on the growth of Blastocystis sp. subtype 3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36064620" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Infection with pathogenic Blastocystis ST7 is associated with decreased bacterial diversity and altered gut microbiome profiles in diarrheal patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35716924" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Alteration of gut bacteria composition among individuals with asymptomatic Blastocystis infection: A case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35281435" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Collateral Damage in the Human Gut Microbiome - Blastocystis Is Significantly Less Prevalent in an Antibiotic-Treated Adult Population Compared to Non-Antibiotic Treated Controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34384477" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Blastocystis in the faeces of children from six distant countries: prevalence, quantity, subtypes and the relation to the gut bacteriome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1671894" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Blastocystis hominis: commensal or pathogen?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10414382" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37185159" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Circulation and colonisation of Blastocystis subtypes in schoolchildren of various ethnicities in rural northern Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37037433" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Site-Specific Incidence Rate of Blastocystis hominis and Its Association with Childhood Malnutrition: Findings from a Multi-Country Birth Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10442423" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Irritable bowel syndrome in patients with Blastocystis hominis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15100450" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15689092" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Blastocystis hominis infection in irritable bowel syndrome patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19393117" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20532564" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28087441" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26784888" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Molecular Characterization and Subtyping of Blastocystis Species in Irritable Bowel Syndrome Patients from North India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35809577" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Prevalence and subtype diversity of Blastocystis sp. in an Iraqi population with and without irritable bowel syndrome (IBS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35390312" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Investigation of Dientamoeba fragilis and Blastocystis in patients from Turkey with ulcerative colitis and irritable bowel syndrome: Any relation with genotypes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34592369" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The neglected role of Blastocystis sp. and Giardia lamblia in development of irritable bowel syndrome: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20922413" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Association of Blastocystis hominis genetic subtypes with urticaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25976414" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Blastocystis and urticaria: Examination of subtypes and morphotypes in an unusual clinical manifestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36584787" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Possible microRNA-based mechanism underlying relationship between chronic spontaneous urticaria and Blastocystis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36108617" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Relationship between Blastocystis spp. with Accompanying Food Hypersensitivity and Chronic Spontaneous Urticaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35413246" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Evaluation of association with subtypes and alleles of Blastocystis with chronic spontaneous urticaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8578192" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Blastocystis hominis in human immunodeficiency virus-related diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8042662" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Blastocystis hominis infection and intestinal injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2563129" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Blastocystis hominis chronic diarrhoea in AIDS patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34528202" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Association between Blastocystis sp. infection and immunocompromised patients: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33246090" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Worldwide prevalence of emerging parasite Blastocystis in immunocompromised patients: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2322029" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Infective arthritis due to Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19068678" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Cytologic diagnosis of blastocystis hominis in peritoneal fluid: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25528951" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Acute blastocystis-associated appendicular peritonitis in a child, Casablanca, Morocco.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9158042" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Epidemiologic survey of Blastocystis hominis infection in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2229995" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Frequency of recovery of Blastocystis hominis in clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15168139" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Comparison of methods for detecting Blastocystis hominis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12650658" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7876972" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Enzyme-linked immunosorbent assay for detection of serum antibody to Blastocystis hominis in symptomatic infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18488250" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Detection of Blastocystis from stool samples using real-time PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21292905" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of blastocystis sp. in clinical stool samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35403959" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Development and evaluation of a loop-mediated isothermal amplification (LAMP) technique for rapid, accurate, and specific detection of Blastocystis spp. in AIDS patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36440639" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6122766" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : The treatment of intestinal protozoan infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8911453" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Resistance of Blastocystis hominis cysts to metronidazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10357863" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Isolate resistance of Blastocystis hominis to metronidazole.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30794628" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25987633" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : In Vitro Antimicrobial Susceptibility Patterns of Blastocystis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24243286" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Treatment failure in patients with chronic Blastocystis infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8237719" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Urticaria by Blastocystis hominis. Successful treatment with paromomycin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23053509" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Is paromomycin the drug of choice for eradication of Blastocystis in adults?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16234044" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
